Tissue cytokine and chemokine expression in inflammatory bowel disease.
about
Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces.Effect of RANTES gene promoter genotypes in patients with ulcerative colitis.Selective upregulation of immune regulatory and effector cytokine synthesis by intestinal intraepithelial lymphocytes following CD43 costimulation.CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma.Evaluation of selected cytokine gene expression in colonic mucosa from dogs with idiopathic lymphocytic-plasmacytic colitis.Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.Plasma interleukin-18 reflects severity of ulcerative colitis.Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis.Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.P-selectin can support both Th1 and Th2 lymphocyte rolling in the intestinal microvasculature.The anti-inflammatory activity of a novel fused-cyclopentenone phosphonate and its potential in the local treatment of experimental colitis.Cobalt ions induce chemokine secretion in a variety of systemic cell linesEndogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease.Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro.T-cell activation in the intestinal mucosa.Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.Age-associated remodeling of the intestinal epithelial barrier.Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ miceN-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot studyIL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine.The atypical chemokine receptor D6 contributes to the development of experimental colitis.Review paper: Implications of the "cancer stem cell" hypothesis on murine models of colon cancer and colitis-associated cancer.Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway.Original Research: Extract of Bambusae Caulis in Taeniam inhibits cigarette smoke-induced pulmonary and intestinal inflammation.CCL5 as an adjuvant for cancer immunotherapy.Platelet secretion: From haemostasis to wound healing and beyond.Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis.Gene expression profile of LPS-stimulated dendritic cells induced by a recombinant Sj16 (rSj16) derived from Schistosoma japonicum.Genes differentially regulated by NKX2-3 in B cells between ulcerative colitis and Crohn's disease patients and possible involvement of EGR1.Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: insights from in vitro and in vivo experimental studies.Ephrin-B reverse signaling induces expression of wound healing associated genes in IEC-6 intestinal epithelial cellsNeutrophil differentiated HL-60 cells model Mac-1 (CD11b/CD18)-independent neutrophil transepithelial migration.Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma.Reactivation of Intestinal Inflammation Is Suppressed by Catestatin in a Murine Model of Colitis via M1 Macrophages and Not the Gut Microbiota.Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1.Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's diseaseCSF-1 regulates the function of monocytes in Crohn's disease patients in remission.Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts.
P2860
Q30906033-B6BD5D51-48DF-4AC4-AFEC-00DE09953A8AQ33733566-4A069546-3D9E-478C-96FC-6CC282F773AEQ33951423-8BE8F08C-47BF-4862-BC02-B777CBD1FDCAQ34233838-222EA905-6D33-4B6E-8ABD-B4C46D1BB55DQ34456956-E2B88FB4-CABC-4807-837E-3CB271B3A996Q34573050-E38F0FF2-E1EE-4D22-B500-3BF86AF075C8Q34605860-6B0A7128-6AC1-4E17-8CF7-948B41AC5100Q34778713-3DE9AFC4-5328-4428-A139-8123873DFC66Q35047787-038AD299-0528-4284-A719-305A0A2A5977Q35094442-BDC5560D-76EA-4168-A5C3-D7013B927481Q35534551-2BD74EE4-357B-4B9E-814A-3AD222655DF7Q35550097-1ABF899C-0D6C-4068-ACD7-BFAE583F5A4BQ35690113-440EE2C1-EDBA-4303-A422-9FD8D40D0CFAQ36500685-AEB01D21-2816-42FC-A6D6-E6E8F1815908Q36732698-407E556C-0BAA-4906-8D39-A4885C1ECBF4Q36733448-57D18C0D-8391-429D-9CB5-78270DD11D3CQ37081643-DFA1ABF5-E024-4AC2-8D99-9FB1FFECEDBDQ37185263-52E84998-DBD9-4BC7-81AD-B8651CEC4F28Q37261921-4B0E152F-9B91-4CFD-9AE4-418C6202AA9CQ37362590-53F8D029-9D56-42B0-BD0D-849A291521C5Q37450168-22FB0DCD-24FA-4DE9-8659-7F83C6C84588Q37476480-46F503DB-BC77-42DD-B076-D43E6936EC5FQ37524153-31D42004-A998-476E-A526-2BD9C4BC38FDQ37551125-3E5CBD16-B06D-4B40-93CA-52142AF8CEF8Q37710085-6338F85B-E336-4AE6-8408-352D3BBADC4DQ38281989-F77263EA-5904-4F7C-BA46-55891706136FQ39314390-8A20164D-2354-4473-9861-D603B96270CCQ39455171-F3A28549-1736-4CA8-AF76-02B6AFF3B316Q39463705-BA380E00-F353-4F15-944E-BBD0FA341160Q39524350-052C4A1E-0051-47DB-8F32-E2F58C54A85AQ39676351-2B6D9C3E-2899-4E10-ABC2-CB334B7EBB65Q40437068-F8399B65-E00E-4AF4-916A-9D4F6AF8F00AQ40994190-71CD57F9-61DA-4004-8608-494D51D18AF3Q41487887-709B5499-6265-4DF8-8707-049997198E66Q41828636-4CB584D5-E673-4EA7-A90C-A02EE8A0F70BQ41909650-D001C131-F2F1-4B09-85E8-FDE2A9E9FFC7Q41980597-66F40963-59C3-4837-8177-4D82DACEDB38Q42198256-16E7ED29-1BAD-4087-BE57-4902EE9B1DA3Q42590083-B6B02A29-16E6-4A14-908F-03CBBC7C979FQ42878657-6BB3B901-BBA0-4C7C-81E6-30D9EA74C6E4
P2860
Tissue cytokine and chemokine expression in inflammatory bowel disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tissue cytokine and chemokine expression in inflammatory bowel disease.
@en
Tissue cytokine and chemokine expression in inflammatory bowel disease.
@nl
type
label
Tissue cytokine and chemokine expression in inflammatory bowel disease.
@en
Tissue cytokine and chemokine expression in inflammatory bowel disease.
@nl
prefLabel
Tissue cytokine and chemokine expression in inflammatory bowel disease.
@en
Tissue cytokine and chemokine expression in inflammatory bowel disease.
@nl
P2093
P356
P1476
Tissue cytokine and chemokine expression in inflammatory bowel disease.
@en
P2093
McCormack G
McCormick PA
Moriarty D
O'Donoghue DP
P2888
P304
P356
10.1007/PL00000223
P50
P577
2001-10-01T00:00:00Z